Phathom Pharmaceuticals, Inc. PHAT Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Phathom Pharmaceuticals, Inc. (PHAT) reported operating lease right-of-use assets in other assets of $2.51M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets increased by 546.4% year-over-year, from $388K to $2.51M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets has grown at a 1.9% compound annual growth rate (CAGR), from $2.37M to $2.6M.